Company Filing History:
Years Active: 2009
Title: **Inventor Spotlight: Matthew Russell Johnson**
Introduction
Matthew Russell Johnson, an innovative inventor based in Harlow, GB, has made significant contributions to the field of pharmaceuticals. His expertise in medicinal chemistry has led to the development of novel compounds aimed at addressing critical health issues.
Latest Patents
Matthew holds a patent for pyrrolopyridine derivatives. This invention relates to unique compounds that offer promising applications in pharmaceutical compositions, particularly for the treatment of diseases associated with the cannabinoid receptor. His work focuses on conditions that arise from fluctuations in the receptor's activity, specifically targeting pain relief.
Career Highlights
Matthew is currently employed at Glaxo Group Limited, a global leader in pharmaceutical advancements. His role in developing innovative compounds positions him as a valuable asset to the company and the broader pharmaceutical field.
Collaborations
Throughout his career, Matthew has collaborated with various professionals, including his colleagues Andrew John Eatherton and Gerard Martin Paul Giblin. These partnerships enhance the research and development processes, contributing to the success of their projects within Glaxo Group.
Conclusion
Matthew Russell Johnson exemplifies innovation in the pharmaceutical sector with his dedication to developing effective treatment options. His patent on pyrrolopyridine derivatives showcases his commitment to advancing medical science and improving patient care through innovative solutions.